Merger takes Jacksonville immunotherapy company to Houston – Jacksonville Business Journal
Jacksonville Business Journal |
Merger takes Jacksonville immunotherapy company to Houston
Jacksonville Business Journal TapImmune Inc. (Nasdaq: TPIV), the Jacksonville-based developer of cancer fighting immunotherapies, is merging with Marker Therapeutics Inc., a Minnesota-based developer of similar T-cell therapies. The newly formed company will be based in Houston. TapImmune to acquire Marker Therapeutics |
